111In-Bleomycin scintigraphyによる女性性器悪性腫瘍の診断的価値

木田 利之, 池田 正典, 斉藤 勝

doi:10.3769/radioisotopes.27.9_514

In order to know if it is possible to objectively decide the extent of infiltration of female genital malignant tumors into parametrium by using ¹¹¹In-bleomycin scintigraphy, a fundamental and clinical investigation was made. The result was as follows; 1) The radiochemical purity and stability of ¹¹¹In-BLM were comparatively unchangeable. When this complex was kept at room temperature for a week, there was not more than 2% of the free ¹¹¹In. 2) As to blood clearance, when the blood radioactivity of ¹¹¹In-BLM 5 minutes after the injection was counted as 100%, about 80% of the radioactivity was cleared from the blood in 48 hours. Over 50% of the radioactivity was excreted into the urine in 48 hours. 3) Of 29 cases of female genital malignant tumors, 23 cases (79%) showed positive images. Therefore ¹¹¹In-BLM was found to be one of the suitable radiopharmaceuticals for the diagnosis of female genital malignant tumors. 4) ¹¹¹In-BLM scintigraphy was of great use for deciding the extent of the invasion of carcinoma cervicis uteri into parametrium and for the search of metastasis.

<SUP>111</SUP>In-Bleomycin scintigraphyによる女性性器悪性腫瘍の診断的価値

書誌事項

この論文をさがす

抄録

収録刊行物

キーワード

詳細情報詳細情報について

書き出し

問題の指摘